Skip Navigation LinksVaccine Adverse Event Reporting System. The image includes photgraphs of a couple, a doctor, a women and child, a baby, and an elderly.
     

CDC

Food and Drug Administration (FDA)

Introduction

Frequently Asked Questions

Bibliography

Contact Information

VAERS Form
(PDF 23K)

VAERS Web Submission

VAERS Data

VAERS Continuing Education

Publications

Links

Privacy Policies & Disclaimers

Call VAERS at
1-800-822-7967

VAERS Bibliography: CDC/FDA Publications, 1990 – 2002

  1. Ball,L.K., Ball,R., & Pratt,R.D. (2001).  An assessment of thimerosal use in childhood vaccines.  Pediatrics, 107(5), 1147-1154.
  2. Ball,R., Braun,M.M., & Mootrey,G.T. (2001).  Safety data on meningococcal polysaccharide vaccine from the Vaccine Adverse Event Reporting System.  Clin.Infect.Dis., 32(9), 1273-1280.
  3. Ball,R., Ball,L.K., Wise,R.P., Braun,M.M., Beeler,J.A., & Salive,M.E. (2001).  Stevens-Johnson syndrome and toxic epidermal necrolysis after vaccination: reports to the vaccine adverse event reporting system.  Pediatr.Infect.Dis.J.,  20(2), 219-223.
  4. Ball,R., Ball,L.K., Wise,R., & Braun,M.M. (2001).  Stevens Johnson syndrome after vaccination [letter reply].  Pediatr.Infect.Dis.J., 20(819)
  5. Ball,R. (2002).  Methods for Ensuring Vaccine Safety.  Expert Review of Vaccines, 1, 161-168.
  6. Ball, R., Halsey, N., Braun, M.M., Moulton, L.H., Gale, A.D., Rammohan, K., Wiznitzer, M., Johnson, R., Salive, M. (2002).  Development of case definitions for acute encephalopathy, encephalitis, and multiple sclerosis reports to the Vaccine Adverse Event Reporting System.  Journal of Clinical Epidemiology, 55, 821-830.
  7. Beeler,J., Varricchio,F., & Wise,R. (1996).  Thrombocytopenia after immunization with measles vaccines: review of the vaccine adverse events reporting system (1990 to 1994).  Pediatr.Infect.Dis.J., 15 (1), 88-90.
  8. Braun,M.M., & Ellenberg,S.S. (1997).  Descriptive epidemiology of adverse events after immunization: reports to the Vaccine Adverse Event Reporting System (VAERS), 1991-1994.  J.Pediatr., 131(4), 529-535.
  9. Braun,M.M., Patriarca,P.A., & Ellenberg,S.S. (1997).  Syncope after immunization.  Arch.Pediatr.Adolesc.Med., 151(3), 255-259.
  10. Braun,M.M., Terracciano,G., Salive,M.E., Blumberg,D.A., Vermeer-de Bondt,P.E., Heijbel,H., Evans,G., Patriarca,P.A., & Ellenberg,S.S. (1998).  Report of a US public health service workshop on hypotonic- hyporesponsive episode (HHE) after pertussis immunization.  Pediatrics, 102(5), E52
  11. Braun,M.M., Mootrey,G.T., Salive,M.E., Chen,R.T., & Ellenberg,S.S. (2000).  Infant immunization with acellular pertussis vaccines in the United States: assessment of the first two years' data from the Vaccine Adverse Event Reporting System (VAERS).  Pediatrics, 106(4), E51
  12. Centers for Disease Control and Prevention. (1990).  Current Trends Vaccine Adverse Event Reporting Sytem -- United States.  MMWR - Morbidity & Mortality Weekly Report, 39(41), 730-733.
  13. Centers for Disease Control and Prevention. (1999).  Intussusception among recipients of rotavirus vaccine—United States, 1998-1999.  MMWR - Morbidity & Mortality Weekly Report, 48(27), 577-581.
  14. Centers for Disease Control and Prevention. (1999).  Withdrawal of rotavirus vaccine recommendation.  MMWR - Morbidity & Mortality Weekly Report, 48(43), 1007    
  15. Centers for Disease Control and Prevention. (2000).  Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP).  MMWR - Morbidity & Mortality Weekly Report, Recommendations & Reports. 49(RR-7), 1-10.
  16. Centers for Disease Control and Prevention. (2000).  Use of anthrax vaccine in the United States.  MMWR - Morbidity & Mortality Weekly Report, 49 (RR-15), 1-20.
  17. Chen,R.T., Rastogi,S.C., Mullen,J.R., Hayes,S.W., Cochi,S.L., Donlon,J.A., & Wassilak,S.G. (1994).  The Vaccine Adverse Event Reporting System (VAERS).  Vaccine, 12(6), 542-550.
  18. Chen,R.T., Phillips,L., & Hadler,S. (1995).  Bottom Line: Vaccination benefits far outweigh risks [letter].  The Nations Health,
  19. Chen,R.T., & Rosenthal,S. (1996).  An errant critique that misses the mark.  Arch.Pediatr.Adolesc.Med., 150, 464-465.
  20. DuVernoy,T.S., & Braun,M.M. (2000).  Hypotonic-hyporesponsive episodes reported to the Vaccine Adverse Event Reporting System (VAERS), 1996-1998.  Pediatrics, 106(4), E52
  21. Ellenberg,S.S., & Chen,R.T. (1997).  The complicated task of monitoring vaccine safety.  Public Health Rep., 112(1), 10-20.
  22. Howson,C.P., & Fineberg,H.V. (1992).  Adverse events following pertussis and rubella vaccines. Summary of a report of the Institute of Medicine.  JAMA, 267(3), 392-396.
  23. Institute of Medicine. (2002).  Immunization Safety Review: Multiple Immunizations and Immune Dysfunction.  Washington, DC:  National Academy Press.
  24. Kelso,J.M., Mootrey,G.T., & Tsai,T.F. (1999).  Anaphylaxis from yellow fever vaccine.  J.Allergy Clin.Immunol., 103(4), 698-701.
  25. Lasky,T., Terracciano,G.J., Magder,L., Koski,C.L., Ballesteros,M., Nash,D., Clark,S., Haber,P., Stolley,P.D., Schonberger,L.B., & Chen,R.T. (1998).  The Guillain-Barre syndrome and the 1992-1993 and 1993-1994 influenza vaccines.  N.Engl.J.Med., 339(25), 1797-1802.
  26. Lathrop,S.L., Ball,R., Haber,P., Mootrey,G.T., Braun,M.M., Shadomy,S.V., Ellenberg,S.S., Chen,R.T., & Hayes,E.B. (2002).  Adverse event reports following vaccination for Lyme disease: December 1998-July 2000.  Vaccine, 20(11-12), 1603-1608.
  27. Martin,M., Weld,L.H., Tsai,T.F., Mootrey,G.T., Chen,R.T., Niu,M., & Cetron,M.S. (2001).  Advanced age a risk factor for illness temporally associated with yellow Fever vaccination.  Emerg.Infect.Dis., 7(6), 945-951.
  28. Niu,M.T., Davis,D.M., & Ellenberg,S. (1996).  Recombinant hepatitis B vaccination of neonates and infants: emerging safety data from the Vaccine Adverse Event Reporting System.  Pediatr.Infect.Dis.J., 15(9), 771-776.
  29. Niu,M.T., Salive,M., Krueger,C., & Ellenberg,S.S. (1998).  Two-year review of hepatitis A vaccine safety: data from the Vaccine Adverse Event Reporting System (VAERS).  Clin.Infect.Dis., 26(6), 1475-1476.
  30. Niu,M.T., Rhodes,P., Salive,M., Lively,T., Davis,D.M., Black,S., Shinefield,H., Chen,R.T., & Ellenberg,S.S. (1998).  Comparative safety of two recombinant hepatitis B vaccines in children: data from the Vaccine Adverse Event Reporting System (VAERS) and Vaccine Safety Datalink (VSD).  Journal of Clinical Epidemiology, 51(6), 503-510.
  31. Niu,M.T., Salive,M.E., & Ellenberg,S.S. (1999).  Neonatal deaths after hepatitis B vaccine: the vaccine adverse event reporting system, 1991-1998.  Arch.Pediatr.Adolesc.Med.,  153(12), 1279-1282.
  32. Niu,M.T., Erwin,D.E., & Braun,M.M. (2001).  Data mining in the US Vaccine Adverse Event Reporting System (VAERS): early detection of intussusception and other events after rotavirus vaccination.  Vaccine, 19(32), 4627-4634.
  33. Rosenthal,S., & Chen,R. (1995).  The reporting sensitivities of two passive surveillance systems for vaccine adverse events.  Am.J.Public Health, 85(12), 1706-1709.
  34. Rosenthal,S., Chen,R., & Hadler,S. (1996).  The safety of acellular pertussis vaccine vs whole-cell pertussis vaccine. A postmarketing assessment.  Arch.Pediatr.Adolesc.Med., 150(5), 457-460.
  35. Silvers,L.E., Ellenberg,S.S., Wise,R.P., Varricchio,F.E., Mootrey,G.T., & Salive,M.E. (2001).  The epidemiology of fatalities reported to the vaccine adverse event reporting system 1990-1997.  Pharmacoepidemiol.Drug Safety, 10(4), 279-285.
  36. Silvers L.E., Varriccho FE, Ellenberg SS, Krueger CL, Wise RP, Salive ME. (2002). Pediatric deaths reported after vaccination:  The utility of information obtained from parents.  American Journal of Preventive Medicine; 22:170-176.
  37. Singleton,J.A., Lloyd,J.C., Mootrey,G.T., Salive,M.E., & Chen,R.T. (1999).  An overview of the vaccine adverse event reporting system (VAERS) as a surveillance system. VAERS Working Group.  Vaccine, 17(22), 2908-2917.
  38. Takahashi,H. (2000).  Need for improved vaccine safety surveillance.  Vaccine, 19(9-10), 1004
  39. Takahashi,H., Pool,V., Tsai1 TF, & Chen,R.T. (2000).  Adverse events after Japanese encephalitis vaccination: review of post- marketing surveillance data from Japan and the United States. The VAERS Working Group.  Vaccine, 18(26), 2963-2969.
  40. Varricchio,F. (1998).  The vaccine adverse event reporting system. J.Toxicol.Clin.Toxicol., 36(7), 765-768.
  41. Varricchio F. (2002)  Medication errors reported to the vaccine adverse event reporting system.  Vaccine; 20: 3049-3051.
  42. Verstraeten,T., Baughman,A.L., Cadwell,B., Zanardi,L., Haber,P., & Chen,R.T. (2001).  Enhancing vaccine safety surveillance: a capture-recapture analysis of intussusception after rotavirus vaccination.  Am.J.Epidemiol., 154(11), 1006-1012.
  43. Wattigney,W.A., Mootrey,G.T., Braun,M.M., & Chen,R.T. (2001).  Surveillance for poliovirus vaccine adverse events, 1991 to 1998: impact of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine.  Pediatrics, 107(5), E83
  44. Wise,R.P., Kiminyo,K.P., & Salive,M.E. (1997).  Hair loss after routine immunizations.  JAMA,  278(14), 1176-1178.
  45. Wise,R.P., Salive,M.E., Braun,M.M., Mootrey,G.T., Seward,J.F., Rider,L.G., & Krause,P.R. (2000).  Postlicensure safety surveillance for varicella vaccine.  JAMA, 284(10), 1271-1279.
  46. Wise, R.P., Braun, M.M., Seward, J.F., Mootrey, G.T., Shields, K.E., Salive, M.E., Krause, P.R. (2002). Pharmacoepidemiologic implications of erroneous varicella vaccinations in pregnancy through confusion with Varicella zoster immune globulin. Pharmacoepidemiology and Drug Safety. 11(8), 651-654.
  47. Zanardi,L.R., Haber,P., Mootrey,G.T., Niu,M.T., & Wharton,M. (2001).  Intussusception among recipients of rotavirus vaccine: reports to the vaccine adverse event reporting system.  Pediatrics, 107(6), E97.

Back to Top